This Article Abstract Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rossant, J. Search for Related Content PubMed PubMed Citation Articles by Rossant, J.

(Circulation Research. 1996;78:349-353.)
© 1996 American Heart Association, Inc.

Articles

Mouse Mutants and Cardiac Development

New Molecular Insights Into Cardiogenesis

J. Rossant

From the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada, and the Departments of Molecular and Medical Genetics, and Obstetrics and Gynecology, University of Toronto.

Correspondence to Dr J. Rossant, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Ave, Toronto ON M5G 1X5, Canada. E-mail rossant@mshri.on.ca.

	Abstract

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
Abstract Understanding the genetic control of cardiac development has been greatly assisted by the newly acquired ability to generate targeted mutations in the mouse. A number of mutations in genes that directly or indirectly affect cardiac development have now been reported, and the phenotypes of these mutations have suggested that cardiac development is under complex genetic control. Further analysis of the mouse model system should help elucidate the etiology of human congenital cardiovascular anomalies.

Key Words: cardiogenesis • genetic mutations • mouse

	Introduction

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
Congenital cardiovascular anomalies are the most common form of human birth defect, with a recorded instance of 1 per 200 live births each year in North America. Since a functioning circulatory system is a prerequisite for survival of the fetus to term, many cases of preterm loss must also be ascribed to cardiovascular defects. However, there is still little information on the etiology of most human cardiovascular anomalies.

The mouse provides a useful model system for studying the development of the cardiovascular system because of the detailed embryological information available and the ability to genetically manipulate its genome. Accumulated information has pinpointed several critical time points during mouse gestation when embryonic death can occur.¹ Most of these are related to critical periods in the development of the cardiovascular system, whereas gross anomalies in the development of other organ systems such as the central nervous system or the lungs are compatible with survival to term. There are several aspects of the development of the cardiovascular system that are susceptible to disruption leading to embryonic mortality. During the early stages of postimplantation development, the embryo obtains its nutrition from the uterus by passive diffusion. However, as the embryo grows, passive diffusion is not enough, and the development of the yolk sac circulation is essential for transport of nutrients absorbed by the yolk sac to the developing fetus. Formation of the yolk sac blood islands, which will form both hematopoietic progenitors and endothelial precursors, and development of the heart itself, which will drive the circulation, are thus critical for early survival of the fetus. Once the embryo has reached a certain size (around E9.5 in the mouse), the yolk sac circulation also becomes limiting, and the establishment of a more direct link between the fetal and maternal circulation via the placenta is required. In the mouse, this occurs by fusion between the allantois and the chorion to form the chorioallantoic placenta. Failure of this fusion leads to embryonic mortality around E10.5. Once the embryo has passed these critical points, there are still many other circulatory problems that can lead to embryonic morbidity and mortality. Inefficient pumping action by the heart may lead to circulatory failure at various stages. Instability of the blood vessel walls may cause hemorrhage and death. Inappropriate remodeling of the major blood vessels can also cause problems, especially at birth, when the pulmonary circulation must be established.

In the mouse, there has been a rapid recent accumulation of new single-gene mutations generated by targeted mutagenesis using homologous recombination in embryonic stem cells.^{2 3 4} Because of the sensitivity of the cardiovascular system to disruption leading to lethality, a considerable number of these new mutations have been reported to show defects in the development of the heart or the vascular system. They thus provide a rich source of new information concerning the genetic regulation of cardiovascular development as well as the possible etiology of human cardiovascular anomalies. In this review, I will focus only on those genes whose disruption by targeted mutagenesis has been reported to cause defective development of the heart itself and not on those whose primary role seems to be in the development of the vascular system or the placenta.

It is hard to discern the detailed genetic strategies of heart development from all the disparate information available at this time. However, some commonality of phenotypic effects has been observed, pointing to critical steps in cardiogenesis. The heart is the first organ to develop and function in the fetus, a process requiring the coordinated development of cells derived from several different embryonic lineages, including the myocytes of the myocardium, the endothelial cells of the endocardium, and the cells of the neural crest that form the outflow tracts. Several mutations appear to directly affect the development of the myocardium and may identify critical regulators of the lineage. Mutational analysis has also identified several genes whose roles seem to be primarily in the neural crest derivatives. Further, mutation of genes involved in cell adhesion and in cell-cell communication has shown that the coordination of intercellular events is critical for cardiac development. Beyond these examples (described in more detail below), in which a primary effect on heart development can be fairly clearly demonstrated, there are an ever-increasing number of mutations in which cardiac failure is cited as the cause of death but in which the etiology of the defect is unclear at this time. A list of mutations in which cardiac anomalies have been reported is provided in the Table.

View this table: [in this window] [in a new window]   Table 1. Mouse Mutations With Cardiac Anomalies

	Transcription Factors in the Myocardium

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
There is considerable interest in understanding the genetic regulation of the myogenic lineage of the heart, which is specified soon after gastrulation in the anterior mesoderm region of the embryo. Despite the fact that mammalian cardiac and skeletal muscle cells express several myofilament proteins in common, the molecular mechanisms that have been so elegantly defined for the skeletal myogenic lineages do not appear to apply to the cardiac lineage.²⁷ The myogenic regulatory factors of the myoD-related basic helix-loop-helix family are not expressed in heart muscle, and mutations in these genes do not affect cardiac development.^{28 29 30 31} Presumably, other regulatory pathways are used. Multiple transcription factors have been implicated in cardiac myocyte–specific gene regulation in vitro, but so far, only a few of these factors have proved to be specific to the cardiogenic mesoderm and are expressed early enough to be prime candidates as master regulators of the cardiac muscle lineage. GATA4,³² Mef2C,³³ and Nkx2-5^{34 35} are all expressed in cardiogenic progenitors, and recent mutational analysis supports a role for Nkx2-5, at least, in normal heart morphogenesis.

Nkx2-5 is a member of the NK class of homeodomain proteins and is homologous to the tinman gene,³⁶ which is involved in heart development in Drosophila. Embryos homozygous for a disruption of the Nkx2-5 gene initiate heart formation but fail to undergo normal looping morphogenesis at E8.5.¹² Embryos die soon after, apparently from circulatory insufficiency. Since cardiac myocytes clearly develop in the mutant embryos, Nkx2-5 is not required for cells to enter the cardiac myogenic lineage, but it is required for full development of the myocardial phenotype, especially in the ventricular region. Although mutant cardiomyocytes do express a number of specific markers, they fail to express the ventricular-specific myofilament gene MLC2V. This implicates Nkx2-5 in cardiac myogenic gene regulation but also indicates that it is not a "master regulator," coordinately regulating sets of cardiac-specific genes. However, since there are multiple Nkx-like genes in mammals, which may have some overlapping functions with Nkx2-5,³⁶ a predominant role for this gene family in cardiac muscle specification cannot yet be excluded.

Another gene that has been shown to be involved in cardiac myocyte gene regulation by in vitro studies is the broadly expressed transcription factor TEF-1. A mutation in TEF-1 generated by insertion of a retroviral gene trap vector, not by homologous recombination, does appear to affect normal myocardial development.²⁰ Homozygous embryos die between E11 and E12 and show an abnormally thinning of both the compact layer and the trabeculae of the ventricular wall, leading to cardiac insufficiency. Since TEF-1 has been shown to regulate some cardiac-specific genes, such as cardiac troponin C, T, and I, as well as the myosin heavy chain genes,³⁷ at first glance this phenotype would seem to implicate TEF-1 as a critical regulator of cardiac gene expression. However, the genes known to be regulated by TEF-1 in vitro are still expressed at relatively normal levels in the mutant hearts. Thus, the exact role of TEF-1 in cardiac development is still unclear, nor is it apparent why the sole defect observed in these embryos is in the heart, given the wide expression and proposed functions of the TEF-1 protein.

Mutations in two transcription factor genes, for which there was no prior indication of a possible role in myocardial gene regulation, also cause defects that appear to primarily affect the development of the myocardial layers of the heart. Several groups reported that a null mutation in the N-myc gene causes embryonic lethality around E11 with multiple developmental defects,^{13 14 15} including poor development of the ventricular myocardium and the interventricular septum. Compound heterozygotes carrying both a null and a hypomorphic allele at the N-myc locus survived a little longer than the null mutants and showed a clear cardiac defect,¹⁶ in which the outer compact layer of the ventricular myocardium, but not the inner trabeculae, was deficient. This defect apparently caused cardiac pump failure and fetal death. N-myc is expressed specifically in the compact layer of the myocardium, suggesting that reduction in the myocardium is a primary response to the loss of N-myc. Although N-myc, like other myc genes, is known to be able to trans-activate genes by binding to specific DNA consensus sequences as a heterodimer with the protein, Max,^{38 39} its downstream targets are not known, and so its precise role in the genetic regulation of the myocardium remains to be elucidated.

A very similar cardiac phenotype was observed in embryos carrying a null mutation in RXR-.^{18 19} Retinoid receptors are members of the steroid hormone receptor–related family of ligand-dependent zinc-finger transcription factors.^{40 41} The RXRs can form cooperative heterodimers with RARs, as well as other members of the hormone receptor superfamily,^{42 43} and are thus thought to play a pivotal role in mediating the effects of several hormonal signals. Despite the evidence for an involvement of retinoic acid in various aspects of development, mutating individual RARs did not result in serious developmental defects.^{44 45 46 47 48} Mice mutant for RXR-, on the other hand, died around E14 from cardiac failure.^{18 19} The compact layer of the myocardium and the ventricular septum were drastically thinned, as seen in N-myc mutants. Embryonic vitamin A deficiency causes a similar defect,⁴⁹ supporting the idea that it is specifically the retinoid signaling pathway that is disrupted in the RXR- mutants. Additional defects were seen in various compound mutants between RXR- and the RARs.¹⁹ These defects included persistent truncus arteriosus and aortic arch defects, suggestive of neural crest disruption. Genetic evidence thus supports an involvement of retinoic acid signaling in the development of both the myocardium and the neural crest cells of the developing heart.

Thus, mutations in three rather widely used transcription factors, as well as one cardiac-specific factor, have indicated critical roles for these genes in the development of the myocardium. How these genes fit into the hierarchy of gene control of cardiac myocyte development remains to be seen. Unlike the situation with the development of skeletal muscle, there are relatively few cardiac-specific transcription factors identified so far, and it may be that interactions between specific factors and more general factors, like N-myc and TEF-1, play a more predominant role in the heart than in skeletal muscle.

	Neural Crest Defects

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
A number of mouse mutations have been reported to be associated with the kinds of cardiovascular anomalies that suggest defects in the development of the neural crest component of the heart. For example, mutations in two transcription factor genes, Hoxa3 and Pax3, cause pleiotropic effects, including heart anomalies. Hoxa3 is a member of the Hox gene families, which are involved in establishing positional identity along the body axis.⁵⁰ Mice that are homozygous for a mutation in the Hoxa3 gene survive to term but show multiple anomalies, including defects in the atria, heart valves, and major vessels.⁸ There is considerable evidence that patterning of the segmentally arrayed hindbrain rhombomeres and their associated neural crest is regulated by the Hox genes⁵⁰ ; thus, defects in the neural crest–derived heart structures are not unexpected. It is important to note that a single gene mutation in a critical patterning gene can produce such a wide spectrum of developmental anomalies, since it suggests that complex congenital anomaly syndromes in humans may have simple underlying causes.

In humans, a single gene defect underlies the multiple anomalies in neural crest–derived tissues, including the heart, that typify Waardenburg's syndrome. These patients are heterozygous for a mutation in Pax3,⁵¹ a transcription factor gene related to the Drosophila paired gene. Interestingly, mice carrying mutations in this gene also exist,⁵² not produced by targeted mutagenesis but arising as spontaneous mutations—the Splotch mutants. Among the neural crest phenotypes seen in homozygous Splotch mutants is persistent truncus arteriosus,²⁰ and homozygous embryos die around E13.5 with symptoms of congestive heart failure. Pax3 is strongly expressed in the developing head neural crest as well as in other tissues⁵³ and seems to play a critical role in directing neural crest development.

Humans heterozygous for mutations in the NF1 tumor suppressor gene exhibit the disease neurofibromatosis, in which benign and malignant abnormalities occur in a variety of neural crest–derived tissues.⁵⁴ This suggests that NF1 could also be an important player in neural crest development. The NF1 gene encodes a protein, neurofibromin, that acts as a negative regulator of the Ras protein in signal transduction,^{55 56} and is widely expressed during development.⁵⁷ Mouse embryos homozygous for a mutation in the NF1 gene die around day 14 of development and show multiple defects in organ development as well as hyperplasia of the sympathetic ganglia.^{10 11} Death is attributed to cardiac failure, as evidenced by generalized edema and vascular congestion. The heart is hypoplastic, and the muscle cells are disorganized. Septal defects, persistent truncus arteriosus, and valve abnormalities were also observed. These latter defects are typical of neural crest defects. The associated defects in neural crest–derived ganglia support the idea that the NF1 mutation may have a primary effect in the neural crest cell lineage. Since Ras signaling has been implicated in many developmental processes, it will be interesting to elucidate which signal transduction pathways are regulated by NF1 in the neural crest lineage and how such pathways intersect with nuclear factors like Pax3 and the Hox genes.

	Cell-Cell Adhesion and Cell-Cell Communication

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
Production of a complex organ like the heart requires cells to communicate and coordinate their activity in order to maintain structural and functional integrity. Interactions between extracellular matrix molecules and their receptors, the integrins, have been proposed to play many roles in tissue and organ interactions. Mutations in two such genes, the cell adhesion molecule, VCAM-1,^{24 25} and a component of its receptor, ₄-integrin,⁵ have been shown to cause specific defects in cardiovascular development. In both ligand and receptor mutants, some embryos die around E10.5 because of failure of fusion of the chorion and allantois and subsequent failure to develop the chorioallantoic circulation. ₄-Integrin is expressed on the chorion, whereas VCAM-1 is expressed on the allantois, suggesting that direct interaction between these molecules is a normal part of the process of chorioallantoic fusion. Some embryos manage to circumvent this defect and achieve fusion by other pathways. These embryos mostly die around E12 of cardiac and perhaps placental problems. The most obvious defect in the heart is the breakdown of the epicardium, the thin layer of mesothelial cells overlying the compact layer of the myocardium. Coronary vessels normally develop in the subepicardial space; such vessels are missing in the mutant hearts, and blood is observed in the pericardial cavity. ₄-Integrins are expressed by the epicardial layer, and VCAM-1 is expressed by the underlying myocardium, suggesting that a direct interaction between these layers is required to promote the integrity of the epicardium and to allow coronary vessels to develop. Whether there are also effects on the myocardium itself is less clear. One group reports thinning of the myocardium in VCAM-1 mutants,²⁵ but this could simply result from overall developmental delay caused by circulatory problems.

Another form of cell-cell communication thought to be critical for the development of many organs, especially the heart, is gap junctional communication. Gap junctions are channels between cells made up of hexamers of proteins called connexins, which allow the passage of ions and small molecules between cells. There are at least 12 different connexin proteins expressed in various regions of the body.⁵⁸ In the heart, the connexin43 gene is strongly expressed in cardiac muscle^{59 60} and has been postulated to be critical for the conductance properties of cardiac muscle that maintain the coordinated contraction of the heart. Surprisingly, embryos homozygous for a mutation in the connexin43 gene survive to term and show apparently normal contraction of the heart.⁶ Other connexins, including connexin40 and connexin45, are also expressed in the heart, and it will be necessary to determine whether these connexins can compensate for the loss of connexin43. Connexin43 mice do, however, show a cardiac defect involving a swelling and blockage of the right ventricular outflow tract. This defect causes perinatal mortality that is due to an inability to establish the pulmonary circulation. Exactly why the loss of connexin43 should produce this very specific defect is still unclear. It could still be an indirect consequence of some change of conductance in the cardiac muscle that causes abnormal mechanical load and hence abnormal morphogenesis. However, since the outflow tracts are largely populated by neural crest cells, which undergo complex remodeling during development, gap junctional communication could be involved in coordinating this process.

	Future Directions

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
This brief summary should serve to illustrate the wealth of new material relevant to the heart that is produced by the analysis of mouse mutants. Several mutants have pointed to the direct involvement of specific genes in specific aspects of cardiac development, whereas other mutations have suggested that the normal function of the heart may depend on factors acting outside of the heart tissue itself. The mutations described in the present review are almost all severe lack-of-function mutations, and the phenotypes are concomitantly severe, often resulting in preterm lethality. Milder mutations in the same genes may cause less drastic alterations in cardiac function that may be more similar to the human congenital anomalies observed in infants at term and beyond. Technologies exist to make such mutations in the mouse, and it will be interesting to compare and contrast effects seen in the mouse with some of the human syndromes. Future genetic analysis of mouse mutations will provide a clearer picture of the primary and secondary influences that determine the normal development of the cardiovascular system.

	Selected Abbreviations and Acronyms

 

E (associated with number) = embryonic day RAR = retinoic acid receptor RXR = retinoid X receptor TEF = transcriptional enhancer factor VCAM = vascular cell adhesion molecule

	Acknowledgments

 
The author's own work quoted here was supported by grants from the National Cancer Institute of Canada (Canadian Cancer Society and Terry Fox Foundation) and the Medical Research Council of Canada. Dr Rossant is a Terry Fox Cancer Research Scientist and a Howard Hughes International Scholar.

Received May 26, 1995; accepted November 27, 1995.

	References

Top Abstract Introduction Transcription Factors in the... Neural Crest Defects Cell-Cell Adhesion and Cell-Cell... Future Directions References

 
1. Copp AJ. Death before birth: clues from gene knockouts and mutations. Trends Genet. 1995;11:87-93. [Medline] [Order article via Infotrieve]

2. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts: I. Curr Biol. 1995;5:625-634. [Medline] [Order article via Infotrieve]

3. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts: II. Curr Biol. 1995;5:758-765. [Medline] [Order article via Infotrieve]

4. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts: III. Curr Biol. 1995;5:873-881. [Medline] [Order article via Infotrieve]

5. Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by 4 integrins are essential in placental and cardiac development. Development. 1995;121:549-560. [Abstract]

6. Reaume AG, de Sousa PA, Kulkarni S, Langille BW, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267:1831-1834. [Abstract/Free Full Text]

7. Thomas SA, Matsumoto AM, Palmiter RD. Noradrenaline is essential for mouse fetal development. Nature. 1995;374:643-646. [Medline] [Order article via Infotrieve]

8. Chisaka O, Capecchi MR. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox 1.5. Nature. 1991;350:473-479. [Medline] [Order article via Infotrieve]

9. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CE. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994;8:2953-2963. [Abstract/Free Full Text]

10. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumour predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet. 1994;7:353-361. [Medline] [Order article via Infotrieve]

11. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg A, Jenkins NA, Parada LF, Copeland NG. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 1994;8:1019-1029. [Abstract/Free Full Text]

12. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 1995;9:1654-1666. [Abstract/Free Full Text]

13. Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 1992;6:2248-2257. [Abstract/Free Full Text]

14. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 1992;6:2235-2247. [Abstract/Free Full Text]

15. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development. 1993;117:1445-1455. [Abstract]

16. Moens CB, Stanton BR, Parada LF, Rossant J. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development. 1993;119:485-499. [Abstract]

17. Leveen P, Pekny M, Gebre-Medhin, S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGFß show renal, cardiovascular and hematological abnormalities. Genes Dev. 1994;8:1875-1887. [Abstract/Free Full Text]

18. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM. RXR mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 1994;8:1007-1018. [Abstract/Free Full Text]

19. Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch J-L, Dolle P, Chambon P. Genetic analysis of RXR developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell. 1994;78:987-1003. [Medline] [Order article via Infotrieve]

20. Franz T. Persistent truncus arteriosus in the Splotch mutant mouse. Anat Embryol. 1989;180:457-464. [Medline] [Order article via Infotrieve]

21. Franz T. The Splotch (Sp1H) and Splotch-delayed (Spd) alleles: differential phenotypic effects on neural crest and limb musculature. Anat Embryol. 1993;187:371-377. [Medline] [Order article via Infotrieve]

22. Chen Z, Friedrich GA, Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 1994;8:2293-2301. [Abstract/Free Full Text]

23. Zhou Q-Y, Quaife CJ, Palmiter RD. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature. 1995;374:640-643. [Medline] [Order article via Infotrieve]

24. Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI. Targeted disruption of the murine VCAM1 gene: essential role of VCAM1 in chorioallantoic fusion and placentation. Genes Dev. 1995;9:1-14. [Abstract/Free Full Text]

25. Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow M. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM1) deficient mice. Development. 1995;121:489-503. [Abstract]

26. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is required for early kidney development. Cell. 1993;74:679-691. [Medline] [Order article via Infotrieve]

27. Olson E. Regulation of muscle transcription by the MyoD family: the heart of the matter. Circ Res. 1993;72:1-6. [Abstract/Free Full Text]

28. Rudnicki MA, Schnegelsberg PNJ, Stead RH, Braun T, Arnold H-H, Jaenisch R. MyoD or Myf5 is required for the formation of skeletal muscle. Cell. 1993;75:1351-1359. [Medline] [Order article via Infotrieve]

29. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, Klein WH. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 1993;364:501-506. [Medline] [Order article via Infotrieve]

30. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nabeshima Y. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 1993;364:532-535. [Medline] [Order article via Infotrieve]

31. Zhang W, Behringer RR, Olson EN. Inactivation of the myogenic bHLH gene MRF4 results in upregulation of myogenin and rib anomalies. Genes Dev. 1995;9:1388-1399. [Abstract/Free Full Text]

32. Heikinheimo M, Scrandrett JM, Wilson DB. Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Dev Biol. 1994;164:361-373. [Medline] [Order article via Infotrieve]

33. Edmondson DG, Lyons GE, Martin JF, Ohlson E. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 1994;120:1251-1263. [Abstract]

34. Komuro I, Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A. 1993;90:8145-8149. [Abstract/Free Full Text]

35. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development. 1993;119:419-431. [Abstract]

36. Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in Drosophila. Development. 1993;118:719-729. [Abstract]

37. Kariya K, Farrance IK, Simpson PC. Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1 adrenergic- and a beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter. J Biol Chem. 1993;268:26658-26662. [Abstract/Free Full Text]

38. Blackwood EM, Eisenman RN. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science. 1991;251:1211-1217. [Abstract/Free Full Text]

39. Prendergast GC, Lawe D, Ziff EB. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell. 1991;65:395-407. [Medline] [Order article via Infotrieve]

40. Green S, Chambon P. Nuclear receptors enhance our understanding of transcriptional regulation. Trends Genet. 1988;4:309-314. [Medline] [Order article via Infotrieve]

41. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889-895. [Abstract/Free Full Text]

42. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signalling. Endocr Rev. 1994;15:61-79. [Abstract/Free Full Text]

43. Kastner P, Leid M, Chambon P. The role of nuclear retinoic acid receptors in the regulation of gene expression. In: Blomhoff R, ed. Vitamin A in Health and Disease. New York, NY: Marcel Dekker Inc; 1994:189-238.

44. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P. Function of retinoic acid receptor (RAR) in the mouse. Cell. 1993;73:643-658. [Medline] [Order article via Infotrieve]

45. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, LeMeur M, Chambon P. High postnatal lethality and testis degeneration in retinoic acid receptor (RAR) mutant mice. Proc Natl Acad Sci U S A. 1993;90:7225-7229. [Abstract/Free Full Text]

46. Li E, Sucov HM, Lee K-F, Evans RM, Jaenisch R. Normal development and growth of mice carrying a targeted disruption of the 1 retinoic acid receptor gene. Proc Natl Acad Sci U S A. 1993;90:1590-1594. [Abstract/Free Full Text]

47. Mendelsohn C, Mark M, Dolle P, Dierich A, Gaub M-P, Krust A. Lampron C, Chambon P. Retinoic acid receptor ß2 (RARß2) null mutant mice appear normal. Dev Biol. 1994;166:246-258. [Medline] [Order article via Infotrieve]

48. Luo J, Pasceri P, Conlon RA, Rossant J, Giguere V. Mice lacking all isoforms of retinoic acid receptorß develop normally and are susceptible to the teratogenic effects of retinoic acid. Mech Dev. 1995;52:1-11.

49. Wilson JG, Warkanay J. Aortic arch and cardiac anomalies in the offspring of vitamin A deficient rats. Am J Anat. 1949;85:113-155. [Medline] [Order article via Infotrieve]

50. Hunt P, Krumlauf R. Hox codes and positional specification in vertebrate embryonic axes. Annu Rev Cell Biol. 1992;8:227-256.

51. Tassabehji M, Read AP, Newton VE, Harris R, Balling R, Gruss P, Strachan T. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature. 1992;355:635-636. [Medline] [Order article via Infotrieve]

52. Epstein DJ, Vekemans M, Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell. 1992;67:767-774.

53. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P. Pax-3, a novel murine DNA-binding protein expressed during early neurogenesis. EMBO J. 1991;10:1135-1147. [Medline] [Order article via Infotrieve]

54. Riccardi VM. Neurofibromatosis: past, present and future. N Engl J Med. 1991;324:1283-1285. [Medline] [Order article via Infotrieve]

55. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins FS. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990;63:851-859. [Medline] [Order article via Infotrieve]

56. Xu G, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990;62:599-608. [Medline] [Order article via Infotrieve]

57. Huynh DP, Nechiporuk T, Pulst SM. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol. 1994;161:538-551. [Medline] [Order article via Infotrieve]

58. Beyer EC, Paul DL, Goodenough DA. Connexin family of gap junction proteins. J Membr Biol. 1990;116:187-194. [Medline] [Order article via Infotrieve]

59. Kanter HL, Saffitz JE, Beyer EC. Cardiac myocytes express multiple gap junction proteins. Circ Res. 1992;70:438-444. [Abstract/Free Full Text]

60. Veenstra RD, Wang H-Z, Westphale EM, Beyer EC. Multiple connexins confer distinct regulatory and conductance properties of gap junctions in developing heart. Circ Res. 1992;71:1277-1283.[Abstract/Free Full Text]

This article has been cited by other articles:

				M. Ream, A. M. Ray, R. Chandra, and D. M. Chikaraishi Early fetal hypoxia leads to growth restriction and myocardial thinning Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R583 - R595. [Abstract] [Full Text] [PDF]

				L. J. Wang and E. A. Sobie Mathematical model of the neonatal mouse ventricular action potential Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2565 - H2575. [Abstract] [Full Text] [PDF]

				C. K.L. Phoon, R. P. Ji, O. Aristizabal, D. M. Worrad, B. Zhou, H. S. Baldwin, and D. H. Turnbull Embryonic Heart Failure in NFATc1-/- Mice: Novel Mechanistic Insights From In Utero Ultrasound Biomicroscopy Circ. Res., July 9, 2004; 95(1): 92 - 99. [Abstract] [Full Text] [PDF]

				A. F. M. MOORMAN and V. M. CHRISTOFFELS Cardiac Chamber Formation: Development, Genes, and Evolution Physiol Rev, October 1, 2003; 83(4): 1223 - 1267. [Abstract] [Full Text] [PDF]

				C. K. L. Phoon and D. H. Turnbull Ultrasound biomicroscopy-Doppler in mouse cardiovascular development Physiol Genomics, June 24, 2003; 14(1): 3 - 15. [Abstract] [Full Text] [PDF]

				L. Jussila and K. Alitalo Vascular Growth Factors and Lymphangiogenesis Physiol Rev, July 1, 2002; 82(3): 673 - 700. [Abstract] [Full Text] [PDF]

				M. Nomi, I. Oishi, S. Kani, H. Suzuki, T. Matsuda, A. Yoda, M. Kitamura, K. Itoh, S. Takeuchi, K. Takeda, et al. Loss of mRor1 Enhances the Heart and Skeletal Abnormalities in mRor2-Deficient Mice: Redundant and Pleiotropic Functions of mRor1 and mRor2 Receptor Tyrosine Kinases Mol. Cell. Biol., December 15, 2001; 21(24): 8329 - 8335. [Abstract] [Full Text] [PDF]

				R. Eferl, M. Sibilia, F. Hilberg, A. Fuchsbichler, I. Kufferath, B. Guertl, R. Zenz, E. F. Wagner, and K. Zatloukal Functions of c-Jun in Liver and Heart Development J. Cell Biol., May 31, 1999; 145(5): 1049 - 1061. [Abstract] [Full Text] [PDF]

				N. Mesaeli, K. Nakamura, E. Zvaritch, P. Dickie, E. Dziak, K.-H. Krause, M. Opas, D. H. MacLennan, and M. Michalak Calreticulin Is Essential for Cardiac Development J. Cell Biol., March 8, 1999; 144(5): 857 - 868. [Abstract] [Full Text] [PDF]

				T. Clark, S. Conway, I. Scott, P. Labosky, G Winnier, J Bundy, B. Hogan, and D. Greenspan The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart Development, January 6, 1999; 126(12): 2631 - 2642. [Abstract] [PDF]

				M Tanaka, Z Chen, S Bartunkova, N Yamasaki, and S Izumo The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development Development, January 3, 1999; 126(6): 1269 - 1280. [Abstract] [PDF]

				J. Ya, M. W. Schilham, P. A. J. de Boer, A. F. M. Moorman, H. Clevers, and W. H. Lamers Sox4-Deficiency Syndrome in Mice Is an Animal Model for Common Trunk Circ. Res., November 16, 1998; 83(10): 986 - 994. [Abstract] [Full Text] [PDF]

				D. J. Dumont, L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K. Pajusola, M. Breitman, and K. Alitalo Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3 Science, October 30, 1998; 282(5390): 946 - 949. [Abstract] [Full Text]

				D. J. Henderson and A. J. Copp Versican Expression Is Associated With Chamber Specification, Septation, and Valvulogenesis in the Developing Mouse Heart Circ. Res., September 7, 1998; 83(5): 523 - 532. [Abstract] [Full Text] [PDF]

				S. Srinivasan, H. S. Baldwin, O. Aristizabal, L. Kwee, M. Labow, M. Artman, and D. H. Turnbull Noninvasive, In Utero Imaging of Mouse Embryonic Heart Development With 40-MHz Echocardiography Circulation, September 1, 1998; 98(9): 912 - 918. [Abstract] [Full Text] [PDF]

				G. I. Fishman Timing Is Everything in Life : Conditional Transgene Expression in the Cardiovascular System Circ. Res., May 4, 1998; 82(8): 837 - 844. [Abstract] [Full Text] [PDF]

				J Chen, S. Kubalak, and K. Chien Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis Development, January 5, 1998; 125(10): 1943 - 1949. [Abstract] [PDF]

				P Ruiz-Lozano, S. Smith, G Perkins, S. Kubalak, G. Boss, H. Sucov, R. Evans, and K. Chien Energy deprivation and a deficiency in downstream metabolic target genes during the onset of embryonic heart failure in RXRalpha-/- embryos Development, January 2, 1998; 125(3): 533 - 544. [Abstract] [PDF]

				S. J Conway, D. J Henderson, M. L Kirby, R. H Anderson, and A. J Copp Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse Cardiovasc Res, November 1, 1997; 36(2): 163 - 173. [Abstract] [Full Text] [PDF]

				S P Oh and E Li The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes & Dev., July 15, 1997; 11(14): 1812 - 1826. [Abstract] [PDF]

				Q. Lin, J. Schwarz, C. Bucana, and E. N. Olson Control of Mouse Cardiac Morphogenesis and Myogenesis by Transcription Factor MEF2C Science, May 30, 1997; 276(5317): 1404 - 1407. [Abstract] [Full Text]

				S. Fisher, E Siwik, D Branellec, K Walsh, and M Watanabe Forced expression of the homeodomain protein Gax inhibits cardiomyocyte proliferation and perturbs heart morphogenesis Development, January 11, 1997; 124(21): 4405 - 4413. [Abstract] [PDF]

				L. Sanford, I Ormsby, A. Gittenberger-de Groot, H Sariola, R Friedman, G. Boivin, E. Cardell, and T Doetschman TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes Development, January 7, 1997; 124(13): 2659 - 2670. [Abstract] [PDF]

				M. Jaber, W. J. Koch, H. Rockman, B. Smith, R. A. Bond, K. K. Sulik, J. Ross Jr., R. J. Lefkowitz, M. G. Caron, and B. Giros Essential role of beta -adrenergic receptor kinase 1 in cardiac development and function PNAS, November 12, 1996; 93(23): 12974 - 12979. [Abstract] [Full Text] [PDF]

				B. B. Keller, M. J. MacLennan, J. P. Tinney, and M. Yoshigi In Vivo Assessment of Embryonic Cardiovascular Dimensions and Function in Day-10.5 to -14.5 Mouse Embryos Circ. Res., August 1, 1996; 79(2): 247 - 255. [Abstract] [Full Text]

This Article Abstract Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rossant, J. Search for Related Content PubMed PubMed Citation Articles by Rossant, J.